Mupirocin, 92%
Mupirocin, 92%
Mupirocin, 92%
Thermo Scientific Chemicals

Mupirocin, 92%

CAS: 12650-69-0 | C26H44O9 | 500.629 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
50 mg
100 mg
Catalog number J66347.MC
also known as J66347-MC
Price (EUR)
625,65
Online exclusive
695,00
Save 69,35 (10%)
Each
Quantity:
100 mg
Request bulk or custom format
Price (EUR)
625,65
Online exclusive
695,00
Save 69,35 (10%)
Each
Specifications
Boiling Point672°C
CAS12650-69-0
ChEBICHEBI:7025
Chemical Name or MaterialMupirocin
Flash Point>110°C (230°F)
View more
Mupirocin is involved in inhibition of protein synthesis was reversed by isoleucine and Pseudomonic Acid was shown to inhibit IleRS (isoleucyl-tRNA synthetase) in vitro. It also demonstrates weak inhibitory action on FARSL (phenylalanyl-tRNA synthetase). Efficacy against staphylococci and streptococci including multiply resistant Staphylcoccus aureus and Staphylococcus epidermidis is reported with Pseudomonic Acid.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Mupirocin is involved in inhibition of protein synthesis was reversed by isoleucine and Pseudomonic Acid was shown to inhibit IleRS (isoleucyl-tRNA synthetase) in vitro. It also demonstrates weak inhibitory action on FARSL (phenylalanyl-tRNA synthetase). Efficacy against staphylococci and streptococci including multiply resistant Staphylcoccus aureus and Staphylococcus epidermidis is reported with Pseudomonic Acid.

Solubility
Soluble in DMSO or methanol. Sparingly soluble in water

Notes
Research Use only: Not intended for animal or human diagnostic or therapeutic use.

Typical working concentrations are in the range of 0.25µg/mL-0.39µg/mL.
RUO – Research Use Only

General References:

  1. Andrew E Simor; Tammy L Stuart; Lisa Louie; Christine Watt; Marianne Ofner-Agostini; Denise Gravel; Michael Mulvey; Mark Loeb; Allison McGeer; Elizabeth Bryce; Anne Matlow. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrobial Agents and Chemotherapy. 2007, 51, (11), 3880-3886.
  2. Gaston H.M. Vondenhoff; Arthur Van Aerschot. Aminoacyl-tRNA synthetase inhibitors as potential antibiotics. European Journal of Medicinal Chemistry. 2011, 46, (11), 5227-5236.